RevPages
Quizartinib
by Ada Brown PhD
An Flt-3/Flk-2 inhibitor; In vitro: IC50 = 1.1 nM and 4.2 nM (for FLT3-ITD and wt FLT3, respectively)
Recommended Features
- High purity
- High effectiveness
- cost effective
Review on Quizartinib
Quizartinib is an orally available small molecule with potential antineoplastic activity. Class III receptor tyrosine kinase inhibitor AC220 selectively inhibits class III receptor tyrosine kinases, including FMS-related tyrosine kinase 3 (FLT3/STK1), colony-stimulating factor 1 receptor (CSF1R/FMS), stem cell factor receptor (SCFR/KIT), and platelet derived growth factor receptors (PDGFRs), resulting in inhibition of ligand-independent leukemic cell proliferation and apoptosis.Good quality with reasonable price.-Marry Golden
Related to Quizartinib
Sponsor Ads
About Ada Brown 
PhD
1 connections, 2 recommendations, 38 honor points.Joined APSense since, May 25th, 2015, From New York, United States.
Created on Nov 9th 2016 03:12. Viewed 524 times.
Comments
No comment, be the first to comment.
